MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Mayo Clinic Proceedings.
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Journal of Medical Genetics.
hide from search
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
The Lancet Oncology.
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.